All stock lists
BILL Holdings, Inc. (New York Stock Exchange:BILL)
US · Delayed Price · Currency is USD
Technology · Software - Application
49.92-0.78 (-1.54%)
Market cap
$4.26B
Health Score
Analyst consensus
Listed since
Dec 12, 2019
Website
Insider Score
––Not scored
BILL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
BILL analyst forecast
BILL analyst consensus
Moderate Buy9 ratings
Buy 5 Hold 4 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
BILL 12-month price target
$61.71+24.3% upsideaverage of 7 firms
$77.00High
$50.00Low
Best analysts covering BILL
- Oppenheimer14%success rate · 14 calls
- Canaccord Genuity13%success rate · 8 calls
- Needham6%success rate · 18 calls
- Goldman Sachs0%success rate · 13 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
BILL analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Truist Securities | Hold | — | — | Reiterated | 2026-10-23 |
| Truist Financial | — | $50.00 | -1.3% | — | 2026-10-23 | |
| — | Truist Securities | Hold | — | — | Reiterated | 2026-09-01 |
| Wolfe Research | Outperform | $60.00 | +24.6% | Reiterated | 2026-08-25 | |
| — | BTIG | Buy | — | — | Reiterated | 2026-08-20 |
| — | UBS | Buy | — | — | Reiterated | 2026-08-20 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-08-20 |
| Jefferies | Buy | $56.00 | +17.4% | Reiterated | 2026-08-20 | |
| Morgan Stanley | Equal Weight | $60.00 | +25.8% | Reiterated | 2026-08-20 | |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2026-08-20 |
| — | BMO Capital | Market Perform | — | — | Reiterated | 2026-08-20 |
| — | Truist Securities | Hold | — | — | Reiterated | 2026-07-24 |
| — | Truist Securities | Hold | — | — | Downgraded | 2026-06-10 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-06-05 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-05-19 |
| Truist Financial | — | $45.00 | +12.2% | — | 2026-05-19 | |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2026-05-12 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-05-11 |
| — | Baird | Neutral | — | — | Reiterated | 2026-05-11 |
| Robert W. Baird | — | $54.00 | +29.1% | — | 2026-05-11 | |
| Morgan Stanley | — | $55.00 | +37.0% | — | 2026-05-08 | |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-05-05 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-04-30 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-04-24 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-04-13 |
| Canaccord Genuity | Buy | $77.00 | +51.7% | Reiterated | 2026-02-10 | |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-02-09 |
| — | BTIG | Buy | — | — | Reiterated | 2026-02-06 |
| — | Needham | Buy | — | — | Reiterated | 2026-02-06 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2026-02-06 |
| — | BTIG | Buy | — | — | Reiterated | 2026-02-02 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-01-22 |
| Truist Financial | — | $58.00 | +25.8% | — | 2026-01-20 | |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2026-01-02 |
| — | BTIG | Buy | — | — | Reiterated | 2025-12-12 |
| Needham | Buy | $75.00 | +55.6% | Reiterated | 2025-11-24 | |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-11-19 |
| Truist Financial | — | $60.00 | +23.7% | — | 2025-11-19 | |
| — | Needham | Buy | — | — | Reiterated | 2025-11-07 |
| — | BMO Capital | Market Perform | — | — | Reiterated | 2025-11-07 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-11-07 |
| — | UBS | Buy | — | — | Reiterated | 2025-11-07 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2025-11-07 |
| — | Susquehanna | Positive | — | — | Reiterated | 2025-11-07 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-10-24 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-10-24 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-10-13 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2025-10-01 |
| — | Truist Securities | Buy | — | — | Upgraded | 2025-09-19 |
| — | Wolfe Research | Outperform | — | — | Upgraded | 2025-09-11 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-08-28 |
| — | Needham | Buy | — | — | Reiterated | 2025-08-28 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-08-28 |
| Mizuho | Neutral | $43.00 | -9.9% | Reiterated | 2025-08-28 | |
| Piper Sandler | Neutral | $50.00 | +8.6% | Downgraded | 2025-08-28 | |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2025-08-28 |
| — | BMO Capital | Market Perform | — | — | Reiterated | 2025-08-28 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2025-08-28 |
BILL earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-05 | 0.56 | 0.64 | $399.8M | $414.7M |
| 2026-05-07 | 0.55 | 0.68 | $403.8M | $406.6M |
| 2026-08-19 | 0.71 | 0.84 | $430.5M | $436.2M |
| 2026-11-05 | 0.98 | 0.00 | $438.7M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.